The present invention relates to the use of amphoteric polyamidoamines with MW of 10-100 kDa as antimalarial agents or carriers of antimalarial drugs and to formulations thereof.

Ranucci, E., Ferruti, P., Fenili, F., Manfredi, A., Mauro, N., Fernández-Busquets, X., et al. (2012)Amphoteric polyamidoamines in the treatment of malaria. . Brevetto No. EP20120192633.

Amphoteric polyamidoamines in the treatment of malaria

Mauro, Nicolò;
2012-01-01

Abstract

The present invention relates to the use of amphoteric polyamidoamines with MW of 10-100 kDa as antimalarial agents or carriers of antimalarial drugs and to formulations thereof.
2012
polyamidoamines, malaria, antimalarial, chloroquine, primaquine
Ranucci, E., Ferruti, P., Fenili, F., Manfredi, A., Mauro, N., Fernández-Busquets, X., et al. (2012)Amphoteric polyamidoamines in the treatment of malaria. . Brevetto No. EP20120192633.
File in questo prodotto:
File Dimensione Formato  
EP2732821A1.pdf

accesso aperto

Descrizione: testo brevetto pubblicato
Dimensione 350.04 kB
Formato Adobe PDF
350.04 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/177535
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact